BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22772632)

  • 21. The prognosis of pemphigus patients will be significantly improved in the future.
    Ikeda S; Komiyama E; Ogawa H
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S69-70. PubMed ID: 12677437
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
    Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus.
    Guenova E; Hoetzenecker W; Schaller M; Röcken M; Fierlbeck G
    Acta Derm Venereol; 2008; 88(3):276-7. PubMed ID: 18480931
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppressive therapy for pemphigus vulgaris complicated by malakoplakia of the bladder.
    Jordaan HF; Heyns CF; Allen FJ; Schneider J
    Clin Exp Dermatol; 1990 Nov; 15(6):442-5. PubMed ID: 2279343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erosions on a prolapsed uterine in an old woman: an unusual manifestation of pemphigus vulgaris.
    Ramezani A; Ghandi N; Akhyani M; Daneshpazhooh M; Naraghi ZS; Chams-Davatchi C
    Dermatol Online J; 2009 Sep; 15(9):9. PubMed ID: 19930996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive refractory pemphigus vulgaris that responded to plasmapheresis: a case report.
    Khaddour HH; Zaher D; Kassem T; Hasan A
    J Med Case Rep; 2020 Jul; 14(1):109. PubMed ID: 32682443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemphigus Vulgaris.
    Silva SC; Nasser R; Payne AS; Stoopler ET
    J Emerg Med; 2019 Jan; 56(1):102-104. PubMed ID: 30503724
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trials with therapeutic plasmapheresis in pemphigus vulgaris].
    Neppert J; Meissner K; Voigt H; Meigel W
    Z Hautkr; 1980 Jun; 55(12):783-9. PubMed ID: 7415360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current therapy of pemphigus vulgaris.
    Fellner MJ; Sapadin AN
    Mt Sinai J Med; 2001; 68(4-5):268-78. PubMed ID: 11514914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemphigus: update for the general practitioner.
    Stoopler ET; Pinto A; DeRossi SS
    N Y State Dent J; 2003; 69(7):30-2. PubMed ID: 14552023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recalcitrant pemphigus foliaceus with Kaposi's varicelliform eruption: report of a fatal case.
    Demitsu T; Kakurai M; Azuma R; Hiratsuka Y; Yamada T; Yoneda K
    Clin Exp Dermatol; 2008 Aug; 33(5):681-2. PubMed ID: 18801107
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmapheresis as a supplementary treatment in pemphigus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):763-7. PubMed ID: 7349095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
    Tan-Lim R; Bystryn JC
    J Am Acad Dermatol; 1990 Jan; 22(1):35-40. PubMed ID: 2298963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

  • 38. Minocycline is a useful adjuvant therapy for pemphigus.
    Gaspar ZS; Walkden V; Wojnarowska F
    Australas J Dermatol; 1996 May; 37(2):93-5. PubMed ID: 8687335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes.
    Kardos M; Levine D; Gürcan HM; Ahmed RA
    Obstet Gynecol Surv; 2009 Nov; 64(11):739-49. PubMed ID: 19849866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.